Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

[Research progress of the side effect of the prostaglandin drugs].

Liu XY, Tang L, Peng YH, Chen XM, Wang NL.

Zhonghua Yan Ke Za Zhi. 2013 Nov;49(11):1045-8. Review. Chinese.

PMID:
24555212
2.

Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension.

Erb C, Lanzl I, Seidova SF, Kimmich F.

Adv Ther. 2011 Jul;28(7):575-85. doi: 10.1007/s12325-011-0038-9. Epub 2011 Jun 30.

PMID:
21725844
3.

Latanoprost : an update of its use in glaucoma and ocular hypertension.

Perry CM, McGavin JK, Culy CR, Ibbotson T.

Drugs Aging. 2003;20(8):597-630. Review.

PMID:
12795627
4.

Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.

Easthope SE, Perry CM.

Drugs Aging. 2002;19(3):231-48. Review.

PMID:
12027782
5.

Tafluprost: a novel prostaglandin analog for treatment of glaucoma.

Pantcheva MB, Seibold LK, Awadallah NS, Kahook MY.

Adv Ther. 2011 Sep;28(9):707-15. doi: 10.1007/s12325-011-0055-8. Epub 2011 Aug 18. Review.

PMID:
21858491
6.

Update on prostaglandin analogs.

Hylton C, Robin AL.

Curr Opin Ophthalmol. 2003 Apr;14(2):65-9. Review.

PMID:
12698043
7.

IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma.

Hommer A, Mohammed Ramez O, Burchert M, Kimmich F.

Curr Med Res Opin. 2010 Aug;26(8):1905-13. doi: 10.1185/03007995.2010.492030.

PMID:
20553122
8.

Prostanoids for the management of glaucoma.

Arranz-Marquez E, Teus MA.

Expert Opin Drug Saf. 2008 Nov;7(6):801-8. doi: 10.1517/14740330802465474 . Review.

PMID:
18983226
9.

Tafluprost: the first preservative-free prostaglandin to treat open-angle glaucoma and ocular hypertension.

Swymer C, Neville MW.

Ann Pharmacother. 2012 Nov;46(11):1506-10. doi: 10.1345/aph.1R229. Epub 2012 Oct 23. Review.

PMID:
23092867
10.
12.

[Medical treatments and practices. What should be done when a prostaglandin proves ineffective?].

Nordmann JP.

J Fr Ophtalmol. 2005 Jun;28 Spec No 2:2S41-2S44. Review. French.

13.

Therapeutic uses of prostaglandin F(2α) analogues in ocular disease and novel synthetic strategies.

Dams I, Wasyluk J, Prost M, Kutner A.

Prostaglandins Other Lipid Mediat. 2013 Jul-Aug;104-105:109-21. doi: 10.1016/j.prostaglandins.2013.01.001. Epub 2013 Jan 23.

PMID:
23353557
14.

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.

Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM, Davis AA; Travoprost Study Group.

Am J Ophthalmol. 2001 Oct;132(4):472-84.

PMID:
11589866
15.

Pharmacological therapy for glaucoma: a review.

Hoyng PF, van Beek LM.

Drugs. 2000 Mar;59(3):411-34. Review. Erratum in: Drugs 2002;62(9):1314.

PMID:
10776828
17.
18.

Therapeutic potential of prostaglandin analogues in glaucoma.

Lindén C.

Expert Opin Investig Drugs. 2001 Apr;10(4):679-94. Review.

PMID:
11281818
19.

Persistence and adherence with topical glaucoma therapy.

Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM.

Am J Ophthalmol. 2005 Oct;140(4):598-606.

PMID:
16226511
20.

Supplemental Content

Support Center